Watertown, MA, United States of America

Reuben Renee Gonzales Perez


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Reuben Renee Gonzales Perez

Introduction:

Reuben Renee Gonzales Perez, based in Watertown, MA, is a noteworthy inventor recognized for his contributions to the field of medical assays. With one patented innovation to his name, Perez has made strides in detecting preimplantation factor (PIF) and its related peptides, an area significant in reproductive biology.

Latest Patents:

Reuben's patent, titled "Assays for Preimplantation Factor and Preimplantation Factor Peptides," addresses methods for detecting PIF's presence. The patent details a novel flow cytometry assay utilizing fluorescently labeled antibodies that significantly enhance understanding of PIF's behavior and its effects on lymphocyte aggregation and viability. His innovation implies a new approach to monitoring PIF through various mechanisms, including the binding dynamics of monoclonal antibodies to CD2 in Jurkat cell cultures, providing valuable insights for future research.

Career Highlights:

Currently, Reuben is affiliated with Bioincept, LLC, where he applies his expertise in assay development and innovation. His dedication to advancing medical diagnostics has established him as a key player within his organization, contributing to further research and development initiatives in the realm of fertility and cell research.

Collaborations:

Throughout his career, Reuben has collaborated with esteemed colleagues, including Eytan R Barnea and Paul C Leavis. These partnerships reflect a commitment to fostering innovation through teamwork and shared expertise, essential components in the world of scientific research and development.

Conclusion:

Reuben Renee Gonzales Perez stands as an inspiring figure in the realm of innovation, particularly in medical diagnostics. His patent provides a crucial advancement in the detection of preimplantation factors, opening doors for future studies that may significantly impact reproductive health. As he continues to work at Bioincept, LLC, the scientific community eagerly anticipates the potential developments stemming from his ongoing research and collaborations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…